Our Work
Latham & Watkins Advises Khosla Ventures on Investment in Somite
May 13, 2025
Emerging Companies & Growth team represented the VC firm in its participation in the TechBio company’s US$47 million Series A funding round.
Somite AI, a TechBio company leveraging foundation models and proprietary AI to accelerate human cell therapy development, has announced it has closed a Series A funding round, raising more than US$47 million. The round was led by Khosla Ventures.
Latham & Watkins LLP represented Khosla Ventures in the funding round with an Emerging Companies & Growth team led by Bay Area partner Jim Morrone, with associates Jack McKay and Christopher Siino. Advice was also provided on intellectual property matters by San Diego counsel Robert Yeh, with associate Kristina Funahashi.